BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15858653)

  • 21. Revised structure of a homonojirimycin isomer from Aglaonema treubii: first example of a naturally occurring alpha-homoallonojirimycin.
    Martin OR; Compain P; Kizu H; Asano N
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3171-4. PubMed ID: 10560746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and inhibitory activities of novel C-3 substituted azafagomines: a new type of selective inhibitors of α-L-fucosidases.
    Moreno-Clavijo E; Carmona AT; Moreno-Vargas AJ; Rodríguez-Carvajal MA; Robina I
    Bioorg Med Chem; 2010 Jul; 18(13):4648-60. PubMed ID: 20570156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A xylobiose-derived isofagomine lactam glycosidase inhibitor binds as its amide tautomer.
    Gloster T; Williams SJ; Tarling CA; Roberts S; Dupont C; Jodoin P; Shareck F; Withers SG; Davies GJ
    Chem Commun (Camb); 2003 Apr; (8):944-5. PubMed ID: 12744311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
    Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
    J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of glycosidase inhibitors: gem-difluoromethylenated nojirimycin analogues.
    Wang RW; Qiu XL; Bols M; Ortega-Caballero F; Qing FL
    J Med Chem; 2006 May; 49(10):2989-97. PubMed ID: 16686540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iminosugars: potential inhibitors of liver glycogen phosphorylase.
    Jakobsen P; Lundbeck JM; Kristiansen M; Breinholt J; Demuth H; Pawlas J; Candela MP; Andersen B; Westergaard N; Lundgren K; Asano N
    Bioorg Med Chem; 2001 Mar; 9(3):733-44. PubMed ID: 11310609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereoselective synthesis and glycosidase inhibitory activity of 3,4-dihydroxy-pyrrolidin-2-one, 3,4-dihydroxy-piperidin-2-one and 1,2-dihydroxy-pyrrolizidin-3-one.
    Coutrot P; Claudel S; Didierjean C; Grison C
    Bioorg Med Chem Lett; 2006 Jan; 16(2):417-20. PubMed ID: 16271473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective total synthesis of aminoiminohexitols via carbamate annulation.
    Win-Mason AL; Jongkees SA; Withers SG; Tyler PC; Timmer MS; Stocker BL
    J Org Chem; 2011 Dec; 76(23):9611-21. PubMed ID: 22022891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of 2-acetamidomethyl derivatives of isofagomine as potential inhibitors of human lysosomal beta-hexosaminidases.
    van den Berg RJ; Donker-Koopman W; van Boom JH; Aerts HM; Noort D
    Bioorg Med Chem; 2004 Mar; 12(5):891-902. PubMed ID: 14980601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-alkyl-3-decarboxy-3-hydroxymethylsiastatin B, a new family of glycosidase inhibitors of gem-diamine 1-N-iminosugars.
    Kondo KI; Adachi H; Nishimura Y; Takeuchi T
    Nat Prod Lett; 2001; 15(6):371-5. PubMed ID: 11838974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and glycosidase inhibition potency of all-trans substituted 1-C-perfluoroalkyl iminosugars.
    Massicot F; Plantier-Royon R; Vasse JL; Behr JB
    Carbohydr Res; 2018 Jul; 464():2-7. PubMed ID: 29777947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramolecular reductive cyclization strategy to the synthesis of (-)-6-methyl-3-hydroxy-piperidine-2-carboxylic acid, (+)-6-methyl-(2-hydroxymethyl)-piperidine-3-ol and their glycosidase inhibitory activity.
    Pawar VU; Chavan ST; Sabharwal SG; Shinde VS
    Bioorg Med Chem; 2010 Nov; 18(22):7799-803. PubMed ID: 20971014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. α-Geminal dihydroxymethyl piperidine and pyrrolidine iminosugars: synthesis, conformational analysis, glycosidase inhibitory activity, and molecular docking studies.
    Pawar NJ; Parihar VS; Chavan ST; Joshi R; Joshi PV; Sabharwal SG; Puranik VG; Dhavale DD
    J Org Chem; 2012 Sep; 77(18):7873-82. PubMed ID: 22873702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homoisofagomines: chemical-enzymatic synthesis and evaluation as alpha- and beta-glucosidase inhibitors.
    Schuster M
    Bioorg Med Chem Lett; 1999 Feb; 9(4):615-8. PubMed ID: 10098675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful β-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal β-galactosidase.
    Thonhofer M; Weber P; Santana AG; Fischer R; Pabst BM; Paschke E; Schalli M; Stütz AE; Tschernutter M; Windischhofer W; Withers SG
    Bioorg Med Chem Lett; 2016 Mar; 26(5):1438-42. PubMed ID: 26838810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General synthesis and biological evaluation of alpha-1-C-substituted derivatives of fagomine (2-deoxynojirimycin-alpha-C-glycosides).
    Goujon JY; Gueyrard D; Compain P; Martin OR; Ikeda K; Kato A; Asano N
    Bioorg Med Chem; 2005 Mar; 13(6):2313-24. PubMed ID: 15727880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Looking glass inhibitors: efficient synthesis and biological evaluation of D-deoxyfuconojirimycin.
    Blériot Y; Gretzke D; Krülle TM; Butters TD; Dwek RA; Nash RJ; Asano N; Fleet GW
    Carbohydr Res; 2005 Dec; 340(18):2713-8. PubMed ID: 16274755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescently tagged iminoalditol glycosidase inhibitors as novel biological probes and diagnostics.
    Lundt I; Steiner AJ; Stütz AE; Tarling CA; Ully S; Withers SG; Wrodnigg TM
    Bioorg Med Chem; 2006 Mar; 14(6):1737-42. PubMed ID: 16274997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aziridine carboxylate from D-glucose: synthesis of polyhydroxylated piperidine, pyrrolidine alkaloids and study of their glycosidase inhibition.
    Dhavale DD; Kumar KS; Chaudhari VD; Sharma T; Sabharwal SG; Prakashareddy J
    Org Biomol Chem; 2005 Oct; 3(20):3720-6. PubMed ID: 16211108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.
    Front S; Biela-Banaś A; Burda P; Ballhausen D; Higaki K; Caciotti A; Morrone A; Charollais-Thoenig J; Gallienne E; Demotz S; Martin OR
    Eur J Med Chem; 2017 Jan; 126():160-170. PubMed ID: 27750150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.